SICAGEN INDIA LTD. - 533014 - Related Party Transactions For The Period Ended 31St March, 2019
Pursuant to Regulation 23[9] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations 2015, the details of related party transactions for the period ended 31st March, 2019 are attached. SICAGEN INDIA LTD. - 533014 - Announcement under Regulation 30 (LODR)-Credit Rating
We herewith submit a copy of the credit rating review report (press release) received from M/s.CARE Ratings Ltd for your records please. Sicagen India Ltd - 533014 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report28/05/2019 3 Name of the Certifying Firm R Kannan 4 Name of the Certifying Individual R Kannan 5Membership TypeFCS 6 Membership Number 6718 7 CP No. 3363 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO SICAGEN INDIA LTD. - 533014 - Intimation - Date Of Annual General Meeting And Book Closure
The Board of Directors of the Company at its meeting held on 22nd May 2019 has, inter alia, confirmed the following: 15th Annual General Meeting (AGM) of the Company has been scheduled to be held on Wednesday, the 31st July 2019 at 2.30 p.m. at 'Rajah Annamalai Mandram', Esplanade, Chennai - 600108. The Register of Members & Share Transfer Books shall remain closed from 25th July 2019 to 31st July 2019 (both days inclusive) for the purpose of the aforesaid AGM and also ascertaining entitlement of equity dividend payable to the eligible shareholders for the financial year 2018-19. The record date is 24th July 2019. The equity dividend, if any declared at the aforesaid AGM, shall be paid between 20th August 2019 and 27th August 2019 to the eligible shareholders. SICAGEN INDIA LTD. - 533014 - Board recommends Dividend
Sicagen India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2019, inter alia, has recommendation of equity dividend @ 4% (40 paise per share) for the financial year 2018-19, subject to the approval of shareholders in the ensuing 15th Annual General Meeting. Sicagen India Ltd - 533014 - Audited Financial Results For The Quarter And Year Ended 31 March 2019
The Board of Directors of the Company at their meeting held on 22.05.2019 has, inter alia considered and approved the following: Audited Financial Results (both standalone & consolidated Results) of the Company for the quarter and year ended 31st March 2019. Recommendation of equity dividend @ 4% (40 paise per share) for the financial year 2018-19, subject to the approval of shareholders in the ensuing 15th Annual General Meeting. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, copies of the aforesaid financial Results together with the auditors report and declaration given by Chief Financial Officer are herewith attached. SICAGEN INDIA LTD. - 533014 - Outcome of Board Meeting
the Board of Directors of the Company at their meeting held on 22.05.2019 has, inter alia considered and approved the following: Audited Financial Results (both standalone & consolidated Results) of the Company for the quarter and year ended 31st March 2019. Recommendation of equity dividend @ 4% (40 paise per share) for the financial year 2018-19, subject to the approval of shareholders in the ensuing 15th Annual General Meeting. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, copies of the aforesaid financial Results together with the auditors report and declaration given by Chief Financial Officer are herewith attached. SICAGEN INDIA LTD. - 533014 - Board to consider Dividend
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be hold on May 22, 2019, inter alia, to consider the following:-1. Audited Annual Accounts of the Company for the year ended March 31, 2019.2. Audited Financial! Results (Standalone & Consolidated Results) for the quarter and year ended March 31, 2019.3. Recommendation of equity dividend if any considered, for the financial year 2018-19. SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Consideration Of Audited Annual Accounts For The Year Ended 31St March 2019
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2019 ,inter alia, to consider and approve Audited Annual Accounts of the Company for the year ended 31st March 2019. Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended 31st March 2019. Recommendation of equity dividend if any considered, for the financial year 2018-19.